Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium

被引:18
|
作者
Muzina, David J. [1 ]
机构
[1] Cleveland Clin, Neurol Inst, Ctr Mood Disorders Treatment & Res, Cleveland, OH 44195 USA
关键词
bipolar disorder; lithium; mixed states; neuromodulation; rapid cycling; DOUBLE-BLIND; LONG-TERM; MOOD STABILIZERS; RANDOMIZED-TRIAL; II DISORDER; MANIA; EFFICACY; DEPRESSION; CARBAMAZEPINE; PROPHYLAXIS;
D O I
10.1111/j.1399-5618.2009.00713.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lithium has long been considered as less than ideal in the management of rapid cycling and mixed states in bipolar disorder. However, these forms of bipolarity represent a generally more difficult phase of the illness to treat with any medication. Increasing knowledge about lithium's other beneficial effects, including protection against suicide and neuromodulatory effects which may protect the brain, make it a first-line treatment for any form of bipolar disorder. As newer therapies become available or receive further exploration, we should look to the past and re-embrace lithium as a core therapeutic modality for bipolarity as we move forward in the field, particularly for forms of the disorder such as rapid cycling and mixed states, historically thought to be more treatment resistant.
引用
收藏
页码:84 / 91
页数:8
相关论文
共 50 条